Evidence map›Paper›PMID 25379704›Full record

ArticlePloS one2014

Clinical and molecular epidemiology of haemophilus influenzae causing invasive disease in adult patients.

Carmen Puig, Imma Grau, Sara Marti, Fe Tubau, Laura Calatayud, Roman Pallares, Josefina Liñares, Carmen Ardanuy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Microorganisms · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Non-TypeableInternational journal of molecular sciences · 2020
    Article
  8. Molecular epidemiology of invasive Haemophilus influenzae disease in Portugal: an update of the post-vaccine period, 2011-2018.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  9. Article
  10. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2020
    Article
  11. hicap:Journal of clinical microbiology · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Recognition of conserved antigens by Th17 cells provides broad protection against pulmonaryProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  16. Review
  17. Article
  18. Article
  19. Inactivation of the Thymidylate SynthaseFrontiers in cellular and infection microbiology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Carmen PuigDepartment of Microbiology, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
Imma GrauDepartment of Infectious Diseases, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
Sara MartiDepartment of Microbiology, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
Fe TubauDepartment of Microbiology, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
Laura CalatayudDepartment of Microbiology, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
Roman PallaresDepartment of Infectious Diseases, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
Josefina LiñaresDepartment of Microbiology, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
Carmen ArdanuyDepartment of Microbiology, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
Bellvitge University Hospital · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe epidemiology of invasive Haemophilus influenzae (Hi) has changed since the introduction of the Hi type b (Hib) vaccine. The aim of this study was to analyze the clinical and molecular epidemiology of Hi invasive disease in adults.

methodsClinical data of the 82 patients with Hi invasive infections were analyzed. Antimicrobial susceptibility, serotyping, and genotyping were studied (2008-2013).

resultsMen accounted for 63.4% of patients (whose mean age was 64.3 years). The most frequent comorbidities were immunosuppressive therapy (34.1%), malignancy (31.7%), diabetes, and COPD (both 22%). The 30-day mortality rate was 20.7%. The majority of the strains (84.3%) were nontypeable (NTHi) and serotype f was the most prevalent serotype in the capsulated strains. The highest antimicrobial resistance was for cotrimoxazole (27.1%) and ampicillin (14.3%). Twenty-three isolates (32.9%) had amino acid changes in the PBP3 involved in resistance. Capsulated strains were clonal and belonged to clonal complexes 6 (serotype b), 124 (serotype f), and 18 (serotype e), whereas NTHi were genetically diverse.

conclusionsInvasive Hi disease occurred mainly in elderly and those with underlying conditions, and it was associated with a high mortality rate. NTHi were the most common cause of invasive disease and showed high genetic diversity.

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsComorbidityDiabetes MellitusFemaleGenotypeHaemophilus InfectionsHaemophilus influenzaeHumansMaleMicrobial Sensitivity TestsMiddle AgedMolecular EpidemiologyMolecular TypingAnti-Bacterial Agents

Identifiers

PMID25379704
PMCPMC4224504
OpenAlexW2015149327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.